# Outcome of Treatment With Botulinum toxinA in Patients With Temporomandibular Myofascial Pain

> **NCT07668375** · PHASE4 · COMPLETED · sponsor: **PAEC General Hospital, Islamabad** · enrollment: 118 (actual)

## Conditions studied

- Myofascial Pain - Dysfunction Syndrome of TMJ

## Interventions

- **DRUG:** Botulinum Toxin-A (Botulax - letibotulinumtoxinA)
- **DRUG:** Normal Saline

## Key facts

- **NCT ID:** NCT07668375
- **Lead sponsor:** PAEC General Hospital, Islamabad
- **Sponsor class:** OTHER
- **Phase:** PHASE4
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2026-01-02
- **Primary completion:** 2026-04-01
- **Final completion:** 2026-04-01
- **Target enrollment:** 118 (ACTUAL)
- **Last updated:** 2026-06-25


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07668375

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07668375, "Outcome of Treatment With Botulinum toxinA in Patients With Temporomandibular Myofascial Pain". Retrieved via MORVS 2026-10-20 from https://api.morvs.ai/clinical/NCT07668375. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*